Cynthia Collins

2019

In 2019, Cynthia Collins earned a total compensation of $14.5M as President and Chief Executive Officer at Editas Medicine.

Compensation breakdown

Non-Equity Incentive Plan$143,169
Option Awards$12,436,552
Salary$909,174
Stock Awards$915,400
Other$85,441
Total$14,489,736

Collins received $12.4M in option awards, accounting for 86% of the total pay in 2019.

Collins also received $143.2K in non-equity incentive plan, $909.2K in salary, $915.4K in stock awards and $85.4K in other compensation.

Rankings

In 2019, Cynthia Collins' compensation ranked 363rd out of 13,971 executives tracked by ExecPay. In other words, Collins earned more than 97.4% of executives.

ClassificationRankingPercentile
All
363
out of 13,971
97th
Division
Manufacturing
129
out of 5,701
98th
Major group
Chemicals And Allied Products
39
out of 2,200
98th
Industry group
Drugs
31
out of 1,886
98th
Industry
Biological Products, Except Diagnostic Substances
6
out of 389
99th
Source: SEC filing on April 28, 2020.

Collins' colleagues

We found six more compensation records of executives who worked with Cynthia Collins at Editas Medicine in 2019.

2019

Judith Abrams

Editas Medicine

Chief Medical Officer

2019

Charles Albright

Editas Medicine

Chief Scientific Officer

2019

Vic Myer

Editas Medicine

Chief Technology Officer

2019

Eric Ek

Editas Medicine

Chief Financial Officer

2019

Katrine Bosley

Editas Medicine

Chief Executive Officer

2019

Andrew Hack

Editas Medicine

Chief Financial Officer

News

In-depth

You may also like